The Japanese government has approved the country’s first gene therapeutic drug, Collategene, designed to treat critical limb ischemia. It’s inventor, Morishita, talks about overcoming ...
Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback